Relmada Therapeutics, Inc.
Relmada Therapeutics develops therapies for oncology and central nervous system conditions.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 16Latest story
Relmada Therapeutics develops therapies for oncology and central nervous system conditions.
November 2026
August 2026
July 2026